Caas Capital Management »

Corcept Therapeutics Incorporated shares owned by Caas Capital Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Caas Capital Management from 13F filings

Historical chart of Caas Capital Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Caas Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Caas Capital Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $445k 22k 20.31
2021-12-31 $14M 696k 19.80

More positions owned by Caas Capital Management

Goldman Sachs Call Option (GS)
Microsoft Corporation (MSFT)
Kenvue (KVUE)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Morgan Stanley Com New Call Option (MS)
Amazon Call Option (AMZN)
Bank of America Corporation Call Option (BAC)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Netflix Call Option (NFLX)
Lam Research Corporation Call Option (LRCX)
Chipotle Mexican Grill Call Option (CMG)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Qualcomm Call Option (QCOM)
Wells Fargo & Company Call Option (WFC)

View all positions for Caas Capital Management

Top funds holding Corcept Therapeutics Incorporated

Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Btim
Federated Investors
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Charles Schwab Investment Management
Man Group
Bank of New York Mellon
Norges Bank Investment Management
Millennium Management
Kynam Capital Management
Citadel Advisors

View all funds holding Corcept Therapeutics Incorporated